GUARDANT HEALTH CL. AGUARDANT HEALTH CL. AGUARDANT HEALTH CL. A

GUARDANT HEALTH CL. A

No trades
See on Supercharts
Market capitalization
‪1.87 B‬EUR
−3.875EUR
‪−434.39 M‬EUR
‪510.94 M‬EUR
‪115.88 M‬
Beta (1Y)
1.42

About GUARDANT HEALTH CL. A

Headquarters
Palo Alto
Employees (FY)
‪1.78 K‬
Founded
2011
ISIN
US40131M1099
FIGI
BBG00Y79H2S5
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange GUARDANT HEALTH CL. A stocks are traded under the ticker 5GH.
GUARDANT HEALTH CL. A is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for GUARDANT HEALTH CL. A has a max estimate of 50.760 EUR and a min estimate of 25.380 EUR.
5GH earnings for the last quarter are −0.69 EUR per share, whereas the estimation was −0.92 EUR resulting in a 24.55% surprise. The estimated earnings for the next quarter are −0.78 EUR per share. See more details about GUARDANT HEALTH CL. A earnings.
GUARDANT HEALTH CL. A revenue for the last quarter amounts to ‪135.31 M‬ EUR despite the estimated figure of ‪129.93 M‬ EUR. In the next quarter revenue is expected to reach ‪135.54 M‬ EUR.
Yes, you can track GUARDANT HEALTH CL. A financials in yearly and quarterly reports right on TradingView.
5GH net income for the last quarter is ‪−169.46 M‬ EUR, while the quarter before that showed ‪−81.45 M‬ EUR of net income which accounts for −108.05% change. Track more GUARDANT HEALTH CL. A financial stats to get the full picture.
No, 5GH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 5GH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUARDANT HEALTH CL. A stock right from TradingView charts — choose your broker and connect to your account.
5GH reached its all-time high on Feb 15, 2021 with the price of 155.300 EUR, and its all-time low was 15.700 EUR and was reached on Mar 26, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪1.78 K‬ employees. See our rating of the largest employees — is GUARDANT HEALTH CL. A on this list?
We've gathered analysts' opinions on GUARDANT HEALTH CL. A future price: according to them, 5GH price has a max estimate of 50.76 EUR and a min estimate of 25.38 EUR. Read a more detailed GUARDANT HEALTH CL. A forecast: see what analysts think of GUARDANT HEALTH CL. A and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GUARDANT HEALTH CL. A EBITDA is ‪−471.05 M‬ EUR, and current EBITDA margin is −92.14%. See more stats in GUARDANT HEALTH CL. A financial statements.